Weight Loss Injections Linked to Rapid Weight Regain Post-Treatment: Study Finds
New Delhi: A new analysis by the University of Oxford has found that people taking GLP-1 weight loss drugs typically regain all the weight they lost within a year of stopping the medication. The findings, presented at the European Congress on Obesity, analyzed 11 studies involving both older and newer GLP-1 drugs and revealed a consistent pattern of rapid weight regain after treatment ends.
The study examined data from 6,370 adults across eight randomized controlled trials and three observational studies. On average, patients lost 8kg while on weight loss injections, but regained the lost weight within 10 months after stopping. Even among those using newer, high-dose treatments like semaglutide (Wegovy) and tirzepatide (Mounjaro)—who lost an average of 16 16kg—the weight regain was significant, with patients gaining back 9.6kg within a year. At that pace, the full amount lost could be regained in just over 20 months.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.